Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.

Alamgeer, Muhammad; Ganju, Vinod; Kumar, Beena; Fox, Jane; Hart, Stewart; White, Michelle; Harris, Marion; Stuckey, John; Prodanovic, Zdenka; Schneider-Kolsky, Michal Elisabeth; Watkins, D Neil

Alamgeer, Muhammad; Ganju, Vinod; Kumar, Beena; Fox, Jane; Hart, Stewart; White, Michelle; Harris, Marion; Stuckey, John; Prodanovic, Zdenka; Schneider-Kolsky, Michal Elisabeth; Watkins, D Neil.

Breast Cancer Res ; 16(2): R44, 2014 Apr 24.

Article in En | MEDLINE | ID: mdl-24762066

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Isoenzymes/metabolism; Retinal Dehydrogenase/metabolism; Aldehyde Dehydrogenase 1 Family; Breast Neoplasms/pathology; Cyclophosphamide/administration & dosage; Docetaxel; Drug Administration Schedule; Epirubicin/administration & dosage; Female; Fluorouracil/administration & dosage; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen/metabolism; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Receptor, ErbB-2/metabolism; Taxoids/administration & dosage; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Retinal Dehydrogenase / Isoenzymes Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google